Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission.
Oren PasvolskyRima M SalibaCelina LedesmaUday R PopatAmin AlousiAmanda L OlsonBetul OranChitra HosingQaiser BashirMuzaffar H QazilbashNicholas James ShortFarhad RavandiRichard ChamplinElizabeth J ShpallPartow KebriaeiPublished in: American journal of hematology (2022)